Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $744.9400 (-3.88%) ($743.9800 - $774.2500) on Wed. Mar. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.75% (three month average) | RSI | 49 | Latest Price | $744.9400(-3.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(42%) DIA(32%) VYM(29%) SPLV(27%) | Factors Impacting REGN price | REGN will decline at least -0.875% in a week (0% probabilities). VIXM(-13%) VXX(-8%) UUP(-4%) TBT(-3%) SMH(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.875% (StdDev 1.75%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $758.09 | 5 Day Moving Average | $769.96(-3.25%) | 10 Day Moving Average | $765.58(-2.7%) | 20 Day Moving Average | $758.09(-1.73%) | To recent high | -5% | To recent low | 9.5% | Market Cap | $78.985b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |